OncologyOncology Innovation: The Top Therapeutic Priority in 2025 Innovation: The Top Therapeutic Priority in 2025
Oncology remains the most active and well-funded therapeutic area in US clinical research in 2025, driven by breakthroughs in personalized medicine and immunotherapies. As cancer treatments become more targeted, the complexity of the trials required to validate them has increased exponentially. Researchers are now looking for specific biomarkers and genetic mutations, requiring highly...
0 Комментарии 0 Поделились 4 Просмотры 0 предпросмотр